Google+ Facebook Twitter Twitter

Tech news: June 2023

This month's top tech news stories

Gyros Protein Technologies


Gyros Protein Technologies has launched Gyrolab Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents for the detection of circulating immune complexes of human IgG with cyno anti-human IgG. The kit reagents streamline pre-clinical development of antibody-based therapeutics, enabling immunogenicity screening of drug candidates without drug-specific ADA assay development. The kit removes the need for assay development and provides robust, reproducible, reliable data.



Clinical Diagnostics has announced the addition of Maine Standards VALIDATE Toxoplasma IgG kit for the Roche cobas platforms for easy, fast and reliable documentation of linearity and calibration verification. VALIDATE Toxoplasma IgG offers TOXO IgG for easy, fast, efficient linearity and calibration verification. VALIDATE Toxoplasma IgG test kits are frozen liquid and ready-to-use; simply dispense the solution from each dropper bottle directly into five sample cups and run in replicates to verify the assay’s reportable range.


Heart failure diagnosis

Randox Laboratories has introduced BNP1-32 – an accepted clinical practice for the diagnosis of heart failure due to its high sensitivity and specificity. It is an automated test for levels of BNP, which can be indicative of several comorbid conditions, such as congestive heart failure, coronary heart disease, atrial fibrillation, chronic renal failure and chronic respiratory disease. This control is designed to be used alongside the Acusera range of third-party controls. Randox has also released Prostate-Specific Antigen, which allows testing for indications of prostate cancer and other prostate conditions such as prostatitis and benign prostatic hyperplasia.


Related Articles

eProtein Discovery side-CREDIT_Supplied

Tech round up: June 2024

Best new tech this month

Natural-killer cells attacking a cancer cel - CREDIT - Science-Photolibrary-f0339843

Predictive model for tumour-killing cells

Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.

Vaccine bottle - CREDIT - iStock-Shutterstock-Various

Personalised vaccines: A pioneering new immunotherapy

A look at the international trial of the world’s first personalised mRNA cancer immunotherapy for melanoma and its potential translation to other cancers and diseases.

Oxford Autoimmune Neurology Diagnostic Laboratory -CREDIT-Supplied

My lab: antibodymediated autoimmune neurology

A guided tour of the Oxford Autoimmune Neurology Diagnostic Laboratory.